EquityZen Growth Technology Fund LLC - Series 2054
Raised
$990K
Investors
38
Min Invest
$10,010
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2054 is a Delaware pooled investment fund filed on 2025-08-28 by EquityZen Advisors and Phil Haslett, raising $990K from 38 investors under Rule 506(b) and Section 3(c)(1). The offering has a $10K minimum investment and is part of EquityZen's pre-IPO platform, which operates approximately 1,889 related EDGAR entities facilitating secondary market access to private company shares.
This pre-IPO pooled fund uses the standard 506(b) private placement exemption combined with 3(c)(1) to remain unregistered as an investment company while limiting to 100 beneficial owners. The $10K minimum investment is characteristic of retail-accessible pre-IPO platforms that democratize access to private company secondaries, significantly lower than institutional pre-IPO vehicles which typically require $250K–$1M+ minimums.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Phil Haslett
Executive Officer, Director · New York, NY
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
